NYSE:ENHAEntertainment
A Look At Enhanced Group (ENHA) Valuation After ASCEND001 Trial Milestone And Upcoming Enhanced Games
Clinical trial update puts Enhanced Group (ENHA) in focus
Enhanced Group (ENHA) is attracting fresh attention after releasing aggregate clinical data from its IRB approved ASCEND001 trial and moving into a five year monitoring phase shortly before the inaugural Enhanced Games.
See our latest analysis for Enhanced Group.
Despite the clinical trial milestone and new partnerships around Live Enhanced, the stock’s short term momentum has been weak, with the 7 day share price return down 42.4% and...